IFITM3 and lung carcinoma: In the following years, upregulation of IFITM3 in tumor tissues in comparison with paratumor tissues was confirmed in multiple cancers, such as gastric cancer (44), breast cancer (45), prostate cancer (46), and lung cancer (47).